@CORNBRED excellent post, have read through the study myself and can't see where your conclusion is wrong.
Would also be interested in @2ic thoughts on this, especially since this is one of the few he holds. Looks like if you drop Dy Tb overall recovery down to circa 27% matching the leaching results the annual revenue drops from around $201m USD per year to $177m USD per year. Not a project killer but takes the shine off their NPV and IRR. $37m USD less cashflow per year over 35+ year mine life does take a toll on the NPV. IRR drops from ~22% to ~17% but more concerningly NPV8 drops from $682m USD to $438m USD. Very curious what they get back to you with on this one. At a $105m USD mcap against $438m NPV8 there isn't a whole lot of head room for multi bagging here.
- Forums
- ASX - By Stock
- ARR
- Ann: Scoping Study, low-cost, scalable world-class REE Project
Ann: Scoping Study, low-cost, scalable world-class REE Project, page-39
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ARR (ASX) to my watchlist
|
|||||
Last
26.5¢ |
Change
0.005(1.92%) |
Mkt cap ! $131.0M |
Open | High | Low | Value | Volume |
26.5¢ | 26.5¢ | 25.5¢ | $93.17K | 356.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 62560 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.260 |
6 | 307010 | 0.255 |
3 | 73450 | 0.250 |
2 | 33000 | 0.245 |
5 | 83100 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 62560 | 3 |
0.270 | 10000 | 1 |
0.275 | 68773 | 3 |
0.280 | 112738 | 4 |
0.285 | 12500 | 2 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
ARR (ASX) Chart |